Strs Ohio Harpoon Therapeutics, Inc. Transaction History

Strs Ohio

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$1.78 - $5.02 $45,568 - $128,511	-25,600 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$13.81 - $23.25 $175,387 - $295,275	12,700 Added 98.45%	25,600 $355,000
Q2 2020 Jul 23, 2020	BUY	$11.11 - $24.72 $143,319 - $318,888	12,900 New	12,900 $214,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.